Use of a tissue-free epigenomic circulating tumor DNA (ctDNA) assay for quantification of tumor fraction (TF) and association with outcomes from RADIOHEAD real-world advanced pan-cancer cohort.

Dual Immune Checkpoint Inhibition in Melanoma and PD-L1 Expression: The Jury Is Still Out Clinical trials frequently include multiple end points that mature at different times. The initial report, ...

We read with interest the Article by Marc P Bonaca and colleagues, which showed that the GLP-1 receptor agonist semaglutide improves walking distance by 13% in patients with peripheral artery disease ...

Peripheral artery disease is a severe form of cardiovascular disease affecting more than 230 million individuals worldwide. The correlation of peripheral artery disease with diminished blood flow in ...

By Tarun Sai Lomte Blood-based DNA repair and stress-response signals reveal a brief molecular window preceding Parkinson’s ...